Javascript Disabled Detected

You currently have javascript disabled. Several functions may not work. Please re-enable javascript to access full functionality.

Eli Lilley Stock Down Graded By Goldmen Sachs

Started by fishinghat, Nov 15 2013 01:17 PM

Please log in to reply

2 replies to this topic

#1 fishinghat

Site Partners

Active Members
13,894 posts

LocationMissouri

Posted 15 November 2013 - 01:17 PM

Goldman says that with the generic version of cymbalta coming out in January and no really promising new drugs coming up from Eli Lilley its future is not secure. Goldman lowered their rating of Eli Lilley stock.

Article

http://news.yahoo.co...-192626487.html

Back to top
Report

#2 thismoment

God-like

Active Members
2,514 posts

Posted 15 November 2013 - 02:59 PM

Fishinghat- it looks like Eli-Lilly needs a money-maker to drive the stock up. How about a Cymbalta antidote?

Back to top
Report

#3 equuswoman

Like a Family Member

Active Members
965 posts

LocationSweet Home Alabama
why_joining:
In the future want 2B off Cymbalta! The physicians are no help. Looking for understanding, support & encouragement as I know this is a difficult process. Want 2 be of help 2 others who will find this site looking for same things as I.

Posted 19 November 2013 - 12:24 AM

That would be a money maker for sure.